E

Eric van der Putten

Partner
💼 Partner bei Aglaia →
Über

Eric van der Putten is a Partner at Aglaia Oncology Funds. Aglaia invests in oncology drug development companies, focusing on early-stage breakthrough inventions with the potential to transform cancer treatment. The Aglaia team has decades of experience in cancer research and oncology drug development and has built a reputation in starting up biotech companies focused on oncology drug development since 2004. Aglaia defines the strategic directions of its portfolio companies in collaboration with innovators and entrepreneurs, bringing hands-on experience in designing research and development plans, from early screening and animal feasibility studies through clinical studies. Aglaia has invested in 12 early stage companies, of which 6 were founded by Aglaia, and the team has been involved in the development of more than 100 oncology products.

Schwerpunkte

BioTech, Oncology

Verifizierte Kontakte & Outreach Agenten

Direktes E-Mail-Muster

[email protected] | [email protected]

KI Outreach Agenten Pitch Writer

Erstelle personalisierte Anschreiben basierend auf den genauen Investitionskriterien...

Direkten Partnerkontakt freischalten

Erhalte Zugriff auf verifizierte Kontakte und nutze unseren Outreach Composer, um Anschreiben in Sekundenschnelle zu entwerfen.

Über GRID kontaktieren

100% kostenloses Konto · Start in 1 Klick